Cortical blindness: a rare complication of cyclosporine therapy

R Ghalie; W E Fitzsimmons; D Bennett; H Kaizer

Cortical blindness: a rare complication of cyclosporine therapy

Bone Marrow Transplant. 1990 Aug;6(2):147-9.

Authors

R Ghalie¹, W E Fitzsimmons, D Bennett, H Kaizer

Affiliation

¹ Bone Marrow Transplant Center, Rush-Presbyterian-St Luke's Medical Center, Chicago, IL 60612.

PMID: 2207451

Abstract

We report a bone marrow transplant patient who developed a reversible episode of cortical blindness, a rare complication of cyclosporine therapy. We review previously reported cases and the mechanisms involved in this complication.

Publication types

Case Reports
Review

MeSH terms

Adult
Blindness / chemically induced*
Blindness / diagnosis
Bone Marrow Transplantation / adverse effects
Combined Modality Therapy
Cyclosporins / adverse effects*
Female
Graft vs Host Disease / prevention & control
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / surgery
Visual Cortex / drug effects*
Visual Cortex / physiopathology

Substances

Cyclosporins